Health Care

Outrage over Mylan Pharmaceuticals’ price hikes on EpiPens has the ‘Erin Brockovich’ of food calling for a congressional investigation.

McDonald's is recalling millions fitness bands that had been given away in Happy Meals because they might cause skin irritation or burns to children.

Stocks are moderately lower in midday trading Monday as the market drifts between small gains and losses.

Valeant Pharmaceuticals replaced Robert Rosiello as chief financial officer as the embattled company attempts to normalize operations amid a host of ongoing investigations and class action lawsuits.

Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.

Pfizer will pay $81.50 a share, a 21% premium to Medivation's closing stock price Friday. Medivation shares traded up 20% to $80.47 in early trading as Pfizer shares fell 5 cents to $34.92.

Pfizer makes it official. The company is acquiring cancer drug company Medivation in a deal worth $14 billion

Immediately after the UK voted to leave the European Union, dealmakers thought they were dead in the water...

The insurer warned regulators last month that blocking its planned merger with Humana would force it to abandon the Obamacare exchanges, and now it's following through on its promise.

Aetna warned Justice Department antitrust officials in early July that if Humana deal was blocked, it would reduce its presence in the Affordable Care Act exchanges.